BSE Live
Jan 09, 16:01Prev. Close
392.45
Open Price
390.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 09, 15:59Prev. Close
392.80
Open Price
392.80
Bid Price (Qty.)
384.75 (9)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Aarti Drugs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 185.29 | 131.02 | 124.50 | 116.01 | 95.09 | |
| Net CashFlow From Operating Activities | 250.74 | 143.09 | 69.77 | 174.75 | 133.29 | |
| Net Cash Used In Investing Activities | -33.21 | -61.67 | -73.54 | -106.98 | -98.79 | |
| Net Cash Used From Financing Activities | -215.41 | -80.07 | 3.92 | -68.23 | -33.26 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 2.13 | 1.35 | 0.15 | -0.45 | 1.24 | |
| Cash And Cash Equivalents Begin of Year | 4.64 | 3.29 | 3.15 | 3.60 | 3.58 | |
| Cash And Cash Equivalents End Of Year | 6.77 | 4.64 | 3.29 | 3.15 | 4.82 |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y